OPPENHEIMER ASSET MANAGEMENT INC. - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 10.51 and the average weighting 0.3%.

Quarter-by-quarter ownership
OPPENHEIMER ASSET MANAGEMENT INC. ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$650,000
+5.9%
6,535
+1.5%
0.01%
-8.3%
Q3 2020$614,000
+3.4%
6,439
+21.2%
0.01%0.0%
Q2 2020$594,000
+102.7%
5,311
+31.8%
0.01%
+71.4%
Q1 2020$293,000
+215.1%
4,030
+398.1%
0.01%
+250.0%
Q2 2019$93,000
-16.2%
809
-8.4%
0.00%0.0%
Q1 2019$111,000
-26.0%
883
-20.2%
0.00%
-50.0%
Q4 2018$150,000
+265.9%
1,107
+271.5%
0.00%
+300.0%
Q3 2017$41,0002980.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$36,819,00014.92%
CARDINAL CAPITAL MANAGEMENT LLC /CT 919,994$95,946,0002.93%
Elk Creek Partners, LLC 236,862$24,702,0002.84%
Conestoga Capital Advisors, LLC 619,653$64,624,0001.56%
WOODSTOCK CORP 71,489$7,456,0001.21%
Summit Creek Advisors LLC 70,962$7,401,0001.16%
FALCON POINT CAPITAL, LLC 8,115$846,0001.08%
RICE HALL JAMES & ASSOCIATES, LLC 302,503$31,548,0001.07%
Stephens Investment Management Group LLC 508,100$52,990,0001.00%
Tygh Capital Management, Inc. 55,672$5,806,0000.96%
View complete list of LIGAND PHARMACEUTICALS INC shareholders